HELSINKI, March 19 (Reuters) - Finland has suspended the use
of AstraZeneca COVID-19 vaccine while it investigates
two possible cases of blood clots, the Finnish Institute for
Health and Welfare said on Friday.
The institute said it estimated that the investigation would
take at least one week. It said earlier this week that it had
received any reports of cases of blood clots among people who
had taken the AstraZeneca vaccine in Finland.
(Reporting by Essi Lehto; editing by Niklas Pollard)